- Home
- BHVN vs LEU Comparison
BHVN vs LEU Comparison
Compare BHVN & LEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- LEU
- Stock Information
- Founded
- BHVN 2013
- LEU 1998
- Country
- BHVN United States
- LEU United States
- Employees
- BHVN N/A
- LEU N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- LEU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- BHVN Health Care
- LEU Industrials
- Exchange
- BHVN Nasdaq
- LEU Nasdaq
- Market Cap
- BHVN 1.9B
- LEU 1.6B
- IPO Year
- BHVN 2017
- LEU 1998
- Fundamental
- Price
- BHVN $14.45
- LEU $190.76
- Analyst Decision
- BHVN Strong Buy
- LEU Strong Buy
- Analyst Count
- BHVN 14
- LEU 8
- Target Price
- BHVN $58.85
- LEU $154.57
- AVG Volume (30 Days)
- BHVN 2.1M
- LEU 1.6M
- Earning Date
- BHVN 08-07-2025
- LEU 08-05-2025
- Dividend Yield
- BHVN N/A
- LEU N/A
- EPS Growth
- BHVN N/A
- LEU 40.85
- EPS
- BHVN N/A
- LEU 6.39
- Revenue
- BHVN N/A
- LEU $471,400,000.00
- Revenue This Year
- BHVN N/A
- LEU $3.22
- Revenue Next Year
- BHVN $59.97
- LEU $9.91
- P/E Ratio
- BHVN N/A
- LEU $29.72
- Revenue Growth
- BHVN N/A
- LEU 58.72
- 52 Week Low
- BHVN $13.87
- LEU $33.51
- 52 Week High
- BHVN $55.70
- LEU $211.31
- Technical
- Relative Strength Index (RSI)
- BHVN 33.35
- LEU 89.85
- Support Level
- BHVN $14.95
- LEU $152.16
- Resistance Level
- BHVN $17.73
- LEU $176.62
- Average True Range (ATR)
- BHVN 0.87
- LEU 11.29
- MACD
- BHVN 0.04
- LEU 3.26
- Stochastic Oscillator
- BHVN 15.03
- LEU 76.66
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About LEU Centrus Energy Corp.
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.